Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index; none of the 34 sources its claims cite is checked for support yet.
Abstract
AIMS/HYPOTHESIS: Human pancreatic beta cells may be complicit in their own demise in type 1 diabetes, but how this occurs remains unclear. One potentially contributing factor is hyperexpression of HLA class I antigens. This was first described approximately 30 years ago, but has never been fully characterised and was recently challenged as artefactual. Therefore, we investigated HLA class I expression at the protein and RNA levels in pancreases from three cohorts of patients with type 1 diabetes. The principal aims were to consider whether HLA class I hyperexpression is artefactual and, if not, to determine the factors driving it. METHODS: Pancreas samples from type 1 diabetes patients with residual insulin-containing islets (n = 26) from the Network for Pancreatic Organ donors with Diabetes (nPOD), Diabetes Virus Detection study (DiViD) and UK recent-onset type 1 diabetes collections were immunostained for HLA class I isoforms, signal transducer and activator of transcription 1 (STAT1), NLR family CARD domain containing 5 (NLRC5) and islet hormones. RNA was extracted from islets isolated by laser-capture microdissection from nPOD and DiViD samples and analysed using gene-expression arrays. RESULTS: Hyperexpression of HLA class I was observed in the insulin-containing islets of type 1 diabetes patients from all three tissue collections, and was confirmed at both the RNA and protein levels. The expression of β2-microglobulin (a second component required for the generation of functional HLA class I complexes) was also elevated. Both 'classical' HLA class I isoforms (i.e. HLA-ABC) as well as a 'non-classical' HLA molecule, HLA-F, were hyperexpressed in insulin-containing islets. This hyperexpression did not correlate with detectable upregulation of the transcriptional regulator NLRC5. However, it was strongly associated with increased STAT1 expression in all three cohorts. Islet hyperexpression of HLA class I molecules occurred in the insulin-containing islets of patients with recent-onset type 1 diabetes and was also detectable in many patients with disease duration of up to 11 years, declining thereafter. CONCLUSIONS/INTERPRETATION: Islet cell HLA class I hyperexpression is not an artefact, but is a hallmark in the immunopathogenesis of type 1 diabetes. The response is closely associated with elevated expression of STAT1 and, together, these occur uniquely in patients with type 1 diabetes, thereby contributing to their selective susceptibility to autoimmune-mediated destruction.
Overview
CoChat Summary
TL;DR
This study reports that islet-cell HLA class I hyperexpression is real, reproducible across three type 1 diabetes pancreas cohorts, and present at both protein and RNA levels. The hyperexpression is associated with elevated STAT1, not NLRC5, and is strongest in insulin-containing islets near diagnosis, then declines with disease duration.
Key findings
- HLA class I hyperexpression was observed in insulin-containing islets from all three cohorts and was not seen in controls; it was restricted mainly to insulin-containing islets, while insulin-deficient islets showed normal expression.
- In laser-captured islets, RNA levels were elevated for HLA-A (1.9 ± 0.14-fold), HLA-B (2.15 ± 0.16-fold), HLA-C (2.02 ± 0.09-fold), and β2-microglobulin (2.07-fold) in the DiViD cohort; nPOD showed similar but less marked trends.
- A non-classical HLA molecule, HLA-F, was also upregulated, by 1.71 ± 0.04-fold at the RNA level in DiViD and confirmed at the protein level.
- STAT1 correlated positively with HLA-ABC expression, with Spearman’s r = 0.5454, p < 0.0001; by contrast, NLRC5 did not correlate with HLA-ABC hyperexpression (p = 0.4504).
- HLA-ABC hyperexpression was seen in patients with disease duration up to 11 years and then declined; the proportion of insulin-containing islets hyperexpressing HLA-ABC decreased with duration (r = –0.883, p < 0.0001).
Methods
- Pancreas tissue from 26 type 1 diabetes patients with residual insulin-containing islets and 17 control individuals was analyzed across three cohorts: nPOD, DiViD, and a UK collection.
- FFPE and frozen sections were stained for HLA class I isoforms, STAT1, NLRC5, β2-microglobulin, and islet hormones; islets from nPOD and DiViD were also laser-capture microdissected for RNA extraction.
- Gene-expression arrays were used for RNA analysis, and statistical testing used t tests or Satterthwaite corrected two-sample tests, with p < 0.05 as the significance threshold.
Limitations
- The paper states that the disease process in living patients cannot be studied non-invasively, so conclusions rely on tissue recovered after death or by pancreas biopsy.
- The authors note that HLA-I hyperexpression had previously been studied in relatively few patients, and that earlier RNA studies were limited; this paper addresses that by using more cohorts and samples.
- Evident from the text: the RNA analyses were performed on pooled, laser-captured islets that did not distinguish hyperexpressing from normal islets, or insulin-containing from insulin-deficient islets at collection, which limits cell-level specificity of the transcript data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 16 Not checked · 36 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, it was strongly associated with increased STAT1 expression in all three cohorts.”
- Also stated in: § Signal transducer and activator of transcription 1 (STAT1) expression correlates positively with HLA-ABC hyperexpression in type 1 diabetes · boosted
“This revealed a striking positive correlation between STAT1 and HLA-ABC expression (Fig. 6b, overall Spearman’s r = 0.5454, p < 0.0001).”
§ Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes > Abstract > Results
boostedstates an associationn = 7- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Signal transducer and activator of transcription 1 (STAT1) expression correlates positively with HLA-ABC hyperexpression in type 1 diabetes · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Islet hyperexpression of HLA-ABC was not confined solely to beta cells, but occurred in all islet endocrine cells (Fig. 1, ESM Fig. 1b).”
§ Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes > Results > Lobular hyperexpression of HLA-A, -B and -C (HLA-ABC) in type 1 diabetes
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“it was observed that a non-classical HLA, HLA-F, was also upregulated (by 1.71 ± 0.04-fold) when analysed across all probe sets (Fig. 4a).”
§ Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes > Results > HLA-F expression is also elevated in the ICIs of individuals with recent-onset type 1 diabetes
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Quantification yielded mean ± SEM increases of 1.9 ± 0.14-fold, 2.15 ± 0.16-fold, 2.02 ± 0.09-fold for HLA-A, -B and -C, respectively, and 2.07-fold for β2M.”
§ Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes > Results > Expression of RNA transcripts encoding HLA or β2M in laser-captured, microdissected islets
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Consistent with this, the most pronounced rise was seen in islets harvested by laser-capture microdissection from the six DiViD patients (p = 0.0263; Fig. 6d, ESM Fig. 7), who were studied very close to disease onset.”
§ Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes > Results > Signal transducer and activator of transcription 1 (STAT1) expression correlates positively with HLA-ABC hyperexpression in type 1 diabetes
plainstates an associationn = 6- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
23 more claims
Create a free account to see all 52 claims and to verify the 34 references still open.
- It may state two separate claims as one. 17
- Probably not a substantial claim. 8
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603 · cited 1×
“Raw signal intensity values from all arrays were Robust Multichip Average (RMA) background corrected, quantile normalized, median polish summarized, and log2transformed [25-27].”
MethodAtkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931 · cited 3×
“Despite these limitations, a consensus model has emerged in which type 1 diabetes is envisaged to result from the selective destruction of beta-cells by immune cells infiltrating the islets of Langerhans [1-3, 8, 9].”
Self-citationMicroarray data normalization and transformation
Quackenbush, J. (2002) · Nature Genetics · doi:10.1038/ng1032 · Cited by 1,975 · cited 1×
“Raw signal intensity values from all arrays were Robust Multichip Average (RMA) background corrected, quantile normalized, median polish summarized, and log2transformed [25-27].”
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854 · cited 2×
“Despite these limitations, a consensus model has emerged in which type 1 diabetes is envisaged to result from the selective destruction of beta cells by immune cells infiltrating the islets of Langerhans [1–3, 8, 9].”
A Model-Based Background Adjustment for Oligonucleotide Expression Arrays
Wu, Z., Irizarry, R. A., Gentleman, R., Martinez-Murillo, F., & Spencer, F. (2004) · Journal of the American Statistical Association · doi:10.1198/016214504000000683 · Cited by 1,716 · cited 1×
“Raw signal-intensity values from all arrays were robust multichip average background corrected, quantile normalised, median polish summarised and log 2 transformed [25–27].”
Bottazzo, G. F., Dean, B. M., McNally, J. M., MacKay, E. H., Swift, P. G. F., & Gamble, D. R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508083130604 · Cited by 932 · cited 1×
“This could be achieved in several ways, including via the up-regulated expression of the major histocompatibility complex (HLA class I molecules) [15-17].”
Analysis of islet inflammation in human type 1 diabetes
Willcox, A., Richardson, S. J., Bone, A. J., Foulis, A. K., & Morgan, N. G. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03860.x · Cited by 712 · cited 5×
“1), while insulin-deficient islets (IDIs) displayed normal expression.”
InfluentialSelf-citationCoppieters, K. T., Dotta, F., Amirian, N., Campbell, P. D., Kay, T. W. H., Atkinson, M. A., Roep, B. O., & von Herrath, M. G. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111187 · Cited by 672 · cited 2×
“It is also likely, however, that beta cells are complicit in these events by aberrantly processing and presenting cellular antigens, thereby becoming visible to autoreactive CD8 Tcells [14].”
Self-citationFoulis, A. K., Liddle, C. N., Farquharson, M. A., Richmond, J. A., & Weir, R. S. (1986) · Diabetologia · doi:10.1007/bf00452061 · Cited by 469 · cited 2×
“Hence, deductions regarding pathogenic processes are made from analyses of tissue recovered either after death or by pancreas biopsy in living individuals [4–7].”
NLR family member NLRC5 is a transcriptional regulator of MHC class I genes
Meissner, T. B., Li, A., Biswas, A., Lee, K.-H., Liu, Y.-J., Bayir, E., Iliopoulos, D., van den Elsen, P. J., & Kobayashi, K. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008684107 · Cited by 447 · cited 1×
“NLR familyCARDdomain containing 5 (NLRC5) expression does not correlate with HLA-ABC hyperexpression In order to understand the factors that might drive islet HLA-I hyperexpression in type 1 diabetes, we studied NLRC5, a known transcriptional regulator of HLA-ABC and β2M [31].”
IMMUNOREACTIVE α-INTERFERON IN INSULIN-SECRETING β CELLS IN TYPE 1 DIABETES MELLITUS
Foulis, A., Farquharson, M., & Meager, A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91128-7 · Cited by 446 · cited 1×
“hyperexpression in surrounding cells [35, 36] since HLA class I hyperexpression does not correlate directly with insulitis.”
Leete, P., Willcox, A., Krogvold, L., Dahl-Jørgensen, K., Foulis, A. K., Richardson, S. J., & Morgan, N. G. (2016) · Diabetes · doi:10.2337/db15-1615 · Cited by 326
Self-citationVariation analysis and gene annotation of eight MHC haplotypes: The MHC Haplotype Project
Horton, R., Gibson, R., Coggill, P., Miretti, M., Allcock, R. J., Almeida, J., Forbes, S., Gilbert, J. G. R., Halls, K., Harrow, J. L., et al. (2008) · Immunogenetics · doi:10.1007/s00251-007-0262-2 · Cited by 315 · cited 1×
“HLA-A, -B, -C and -F), probe sets were annotated according to eight major haplotypes incorporated into the human genome assembly, as previously described [28].”
Krogvold, L., Edwin, B., Buanes, T., Frisk, G., Skog, O., Anagandula, M., Korsgren, O., Undlien, D., Eike, M. C., Richardson, S. J., et al. (2015) · Diabetes · doi:10.2337/db14-1370 · Cited by 314
Self-citationThe Pathogenesis and Natural History of Type 1 Diabetes
Atkinson, M. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007641 · Cited by 314 · cited 2×
“Despite these limitations, a consensus model has emerged in which type 1 diabetes is envisaged to result from the selective destruction of beta-cells by immune cells infiltrating the islets of Langerhans [1-3, 8, 9].”
BackgroundSelf-citationFoulis, A. K., Farquharson, M. A., & Hardman, R. (1987) · Diabetologia · doi:10.1007/bf00299027 · Cited by 248 · cited 4×
“However, earlier studies do not support this, since the proportion of ICIs displaying HLA-I hyperexpression in children with recent-onset disease has been reported to be extremely high, suggesting that essentially all such islets hyperexpress HLA-I at diagnosis [15].”
InfluentialBlood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
Arif, S., Leete, P., Nguyen, V., Marks, K., Nor, N. M., Estorninho, M., Kronenberg-Versteeg, D., Bingley, P. J., Todd, J. A., Guy, C., et al. (2014) · Diabetes · doi:10.2337/db14-0365 · Cited by 238 · cited 1×
“In this scenario, CD8 + T cells are considered to be the major effectors of beta cell death, and are directed to the pancreatic islets to participate in the autoimmune assault against beta cells [10–13].”
Self-citationCampbell‐Thompson, M., Wasserfall, C., Kaddis, J., Albanese‐O'Neill, A., Staeva, T., Nierras, C., Moraski, J., Rowe, P., Gianani, R., Eisenbarth, G., et al. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2316 · Cited by 236 · cited 1×
“after death or by pancreas biopsy of living subjects [4-7].”
Self-citationvon Herrath, M. G., & Oldstone, M. B. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.531 · Cited by 221
Insulitis in human type 1 diabetes: The quest for an elusive lesion
In't Veld, P. (2011) · Islets · doi:10.4161/isl.3.4.15728 · Cited by 216
STAT1 Is a Master Regulator of Pancreatic β-Cell Apoptosis and Islet Inflammation
Moore, F., Naamane, N., Colli, M. L., Bouckenooghe, T., Ortis, F., Gurzov, E. N., Igoillo-Esteve, M., Mathieu, C., Bontempi, G., Thykjaer, T., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.162131 · Cited by 178 · cited 1×
“critical protein involved in mediating antiviral responses to interferons and its early upregulation in the progression of type 1 diabetes would be expected to place the beta-cells in a heightened state of responsiveness to these cytokines [41-43].”
Krogvold, L., Edwin, B., Buanes, T., Ludvigsson, J., Korsgren, O., Hyöty, H., Frisk, G., Hanssen, K. F., & Dahl-Jørgensen, K. (2014) · Diabetologia · doi:10.1007/s00125-013-3155-y · Cited by 171 · cited 1×
“Therefore, in the present work, we have taken advantage of a unique collaborative strength achieved by combining three of the world’s most significant collections of pancreas samples from individuals with type 1 diabetes: an archival collection of postmortem samples from the UK [4]; the Network for Pancreatic Organ do…”
Self-citationIFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes.
Thomas, H. E., Parker, J. L., Schreiber, R. D., & Kay, T. W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2899 · Cited by 128 · cited 1×
“Elevated expression of HLA-I has been observed in mouse models of type 1 diabetes, where IFN-γ release from infiltrating immune cells has been shown to be the driver [37, 38].”
Marroqui, L., Dos Santos, R. S., Fløyel, T., Grieco, F. A., Santin, I., Op de beeck, A., Marselli, L., Marchetti, P., Pociot, F., & Eizirik, D. L. (2015) · Diabetes · doi:10.2337/db15-0362 · Cited by 119 · cited 1×
“critical protein involved in mediating antiviral responses to interferons and its early upregulation in the progression of type 1 diabetes would be expected to place the beta-cells in a heightened state of responsiveness to these cytokines [41-43].”
BackgroundDevendra, D., & Eisenbarth, G. S. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.01.008 · Cited by 112 · cited 1×
“hyperexpression in surrounding cells [35, 36] since HLA class I hyperexpression does not correlate directly with insulitis.”
BackgroundWainwright, S. D., Biro, P. A., & Holmes, C. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.319 · Cited by 107 · cited 1×
“surface rather than intracellularly [32].”
Krogvold, L., Wiberg, A., Edwin, B., Buanes, T. A., Jahnsen, F. L., Hanssen, K. F., Larsson, E. N. V., Korsgren, O., Skog, O., & Dahl‐Jørgensen, K. (2015) · Diabetologia · doi:10.1007/s00125-015-3820-4 · Cited by 105 · cited 1×
“Initially, RNA expression profiles were analysed in islets from the DiViD cohort, since these represent patients with recent-onset disease who retained ICIs [29, 30].”
Self-citationPujol‐Borrell, R., Todd, I., Doshi, M., Gray, D. P., Feldmann, M., & Bottazzo, G. F. (1986) · PubMed · Cited by 105
Immunopathology of the human pancreas in type-I diabetes
Richardson, S. J., O’Connell, A., Bone, A. J., Morgan, N. G., & Foulis, A. K. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-010-0205-0 · Cited by 96 · cited 1×
“As noted above, however, we emphasise that, contrary to the situation in mice, hyperexpression of HLA-I can occur in human islets without evidence of insulitis [15, 22, 39, 40].”
Self-citationPancreatic Pathology in Type 1 Diabetes Mellitus
Richardson, S. J., Morgan, N. G., & Foulis, A. K. (2014) · Endocrine Pathology · doi:10.1007/s12022-014-9297-8 · Cited by 91 · cited 2×
“Collectively, such approaches have been applied in few cases worldwide, reflecting the paucity of accessible samples in which the tissue architecture has been preserved and the destructive process is still present and amenable to study [8, 9].”
Self-citationIslet inflammation in human type 1 diabetes mellitus
Morgan, N. G., Leete, P., Foulis, A. K., & Richardson, S. J. (2014) · IUBMB Life · doi:10.1002/iub.1330 · Cited by 87 · cited 1×
“effectors of beta-cell death and these are directed to the pancreatic islets to participate in the autoimmune assault against the beta-cells [10-13].”
Self-citationHLA-F Complex without Peptide Binds to MHC Class I Protein in the Open Conformer Form
Goodridge, J. P., Burian, A., Lee, N., & Geraghty, D. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000078 · Cited by 83 · cited 1×
“It has been demonstrated that HLA-F can interact with open-conformation HLA-I heavy chains (without bound peptide), facilitating migration of the complex to the cell surface [33, 34].”
Heterogeneity and Lobularity of Pancreatic Pathology in Type 1 Diabetes during the Prediabetic Phase
Rodriguez-Calvo, T., Suwandi, J. S., Amirian, N., Zapardiel-Gonzalo, J., Anquetil, F., Sabouri, S., & von Herrath, M. G. (2015) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415576543 · Cited by 77 · cited 3×
“Frozen sections were stained using a standard immunofluorescence approach [22].”
T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive review
Gomez-Touriño, I. M., Arif, S., Eichmann, M., & Peakman, M. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.012 · Cited by 75 · cited 1×
“In this scenario, CD8 + T cells are considered to be the major effectors of beta cell death, and are directed to the pancreatic islets to participate in the autoimmune assault against beta cells [10–13].”
HLA-F and MHC-I Open Conformers Cooperate in a MHC-I Antigen Cross-Presentation Pathway
Goodridge, J. P., Lee, N., Burian, A., Pyo, C., Tykodi, S. S., Warren, E. H., Yee, C., Riddell, S. R., & Geraghty, D. E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300080 · Cited by 74 · cited 1×
“It has been demonstrated that HLA-F can interact with open-conformation HLA-I heavy chains (without bound peptide), facilitating migration of the complex to the cell surface [33, 34].”
A run on the biobank: what have we learned about type 1 diabetes from the nPOD tissue repository?
Kaddis, J. S., Pugliese, A., & Atkinson, M. A. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000171 · Cited by 50 · cited 1×
“Therefore, in the present work, we have taken advantage of the unique collaborative strength achieved by combining three of the world’s most significant collections of pancreas samples from individuals with type 1 diabetes; an archival collection of postmortem samples from the United Kingdom [4], the Network for Pancr…”
BackgroundSelf-citationUse of a systems biology approach to understand pancreatic β-cell death in Type 1 diabetes
Eizirik, D. L., Moore, F., Flamez, D., & Ortis, F. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360321 · Cited by 49 · cited 1×
“critical protein involved in mediating antiviral responses to interferons and its early upregulation in the progression of type 1 diabetes would be expected to place the beta-cells in a heightened state of responsiveness to these cytokines [41-43].”
BackgroundCampbell-Thompson, M. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12286 · Cited by 46
New Insight on Human Type 1 Diabetes Biology: nPOD and nPOD-Transplantation
Pugliese, A., Vendrame, F., Reijonen, H., Atkinson, M. A., Campbell-Thompson, M., & Burke, G. W. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0530-0 · Cited by 45 · cited 7×
“All islets visible in two to five sections from each sample were pooled, and RNA was extracted using the Arcturus PicoPure RNA Isolation Kit (Applied Biosystems, Grand Island, NY, USA).”
InfluentialSelf-citationThe pathology of the endocrine pancreas in type 1 (insulin-dependent) diabetes mellitus
FOULIS, A. K. (1996) · APMIS · doi:10.1111/j.1699-0463.1996.tb00702.x · Cited by 44 · cited 1×
“hyperexpression of HLA-I can occur in human islets without evidence of insulitis [15, 22, 39, 40].”
BackgroundWu, J., Kakoola, D. N., Lenchik, N. I., Desiderio, D. M., Marshall, D. R., & Gerling, I. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046941 · Cited by 31 · cited 2×
“Using the Affymetrix Human Gene 2.0 STarray, CEL files were generated from both control and type 1 diabetic donors, as previously described [24].”
InfluentialSelf-citationSkog, O., Korsgren, S., Wiberg, A., Danielsson, A., Edwin, B., Buanes, T. A., Krogvold, L., Korsgren, O., & Dahl‐Jørgensen, K. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.09.004 · Cited by 27 · cited 6×
“Classification of donors based on HLA-ABC expression Since islet hyperexpression of HLA-ABC has been claimed to be artefactual [18], we monitored the levels of HLA-ABC in a subset of nPOD donors in two independent laboratories using pancreas sections preserved by different methods (frozen vs FFPE).”
InfluentialSelf-citationMarselli, L., Sgroi, D., Bonner-Weir, S., & Weir, G. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-448-3_8 · Cited by 21 · cited 1×
“Islets were recognized by their natural auto-fluorescence [23].”
Background
Cited by
DiMeglio, L. A., Evans-Molina, C., & Oram, R. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31320-5 · Cited by 1,561
Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., Jacobsen, L. M., Schatz, D. A., & Lernmark, Å. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.16 · Cited by 1,475
Zhu, Y., Piehowski, P. D., Zhao, R., Chen, J., Shen, Y., Moore, R. J., Shukla, A. K., Petyuk, V. A., Campbell-Thompson, M., Mathews, C. E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03367-w · Cited by 587
Self-citationThe heterogeneous pathogenesis of type 1 diabetes mellitus
Ilonen, J., Lempainen, J., & Veijola, R. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0254-y · Cited by 494
Autoreactive T cells in type 1 diabetes
Pugliese, A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94549 · Cited by 358
“This observation was confirmed with various methodologies in multiple patient cohorts (26) (Figure 2).”
ResultSelf-citation
Metadata
- Authors
- Richardson, S. J., Rodriguez-Calvo, T., Gerling, I. C., Mathews, C. E., Kaddis, J. S., Russell, M. A., Zeissler, M., Leete, P., Krogvold, L., Dahl-Jørgensen, K., von Herrath, M., Pugliese, A., Atkinson, M. A., & Morgan, N. G.
- Affiliations
- University of Exeter (GB)
- University of Tennessee Health Science Center (US)
- University of Florida Health (US)
- City Of Hope National Medical Center (US)
- Oslo University Hospital (NO)
- University of Miami (US)
- Corresponding author
- Richardson, Sarah J.
- Morgan, Noel G.
- ORCID
- Venue
- Diabetologia
- Published
- 2016-08-09
- Volume
- 59
- Issue
- 11
- Pages
- 2448-2458
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC5042874
- OpenAlex
- W2513957711
- Cited by
- 298
- References
- 43
- Citations by year
- 2026: 26 · 2025: 39 · 2024: 30 · 2023: 23 · 2022: 36 · 2021: 37 · 2020: 28 · 2019: 33 · 2018: 25 · 2017: 19 · 2016: 2
- FWCI
- 21.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Open Research Exeter (University of Exeter) (acceptedVersion)
- Figshare (submittedVersion)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
- Funders
- Seventh Framework Programme (261441)
- Diabetes Research & Wellness Foundation
- National Institutes of Health (UC4 DK104155)
- JDRF (JDRF 25-2012-516)
- South-Eastern Norway Regional Health Authority
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- type 1 diabetes, pancreatic beta cells, islets, STAT1, NLRC5, HLA-F, beta2-microglobulin, islet autoimmunity, immunopathogenesis, recent-onset type 1 diabetes, disease duration, islet gene expression, HLA-ABC
- MeSH terms
- Diabetes Mellitus, Type 1, Female, Fluorescent Antibody Technique, Humans, Immunohistochemistry, Insulin, Islets of Langerhans, Male, Pancreas, Histocompatibility Antigens Class I, STAT1 Transcription Factor, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.